Breaking News

Symbiosis Completes Qualification of New FDP 50 Flexicon Automated Fill/Finish Line 

Enhances its technical capabilities and expands its capacity.

Author Image

By: Charlie Sternberg

Associate Editor

Symbiosis Pharmaceutical Services, a global contract manufacturing organization (CMO) specializing in the sterile manufacture of injectable drug products, has successfully completed qualification of its new FPD 50 Flexicon automated fill/finish line at its new commercial production facility in Stirling, Scotland.  The fully integrated sterile liquid fill/finish system operates under a Grade A Restricted Access Barrier System (RABS). Designed to deliver with both precision and efficiency,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters